MDMG.L Regulatory News (MDMG)

MD MEDICAL GROUP OPENS CLINIC IN KOSTROMA

15 April 2016, Moscow - MD Medical Group Investments Plc ("MD Medical Group", "MDMG" or the "Company" - LSE: MDMG), a leading Russian private healthcare provider, announces the opening of a new clinic in Kostroma.

"Mother and child Kostroma" is the first in the region to offer in vitro fertilisation (IVF); the clinic will provide the first phase of treatment. In addition, the new clinic will provide obstetric and gynecological consultations, pregnancy check-ups, expert ultrasound examinations and prenatal diagnostics. The Kostroma clinic will work in collaboration with the Mother and child clinic in Yaroslavl, which opened in December 2013, and thanks to its technologically advanced equipment, it will carry out the operational and embryological stages of the cycle. The two clinics working in tandem will enable a number of women to access check-ups and treatment in their local area, including by using Mandatory Health Insurance (MHI).

The new clinic will be able to cater for up to 10,000 physician visits per year. Total investments in the first stage have amounted to RUB 6 million, with a possible increase to RUB 15 million in due course.

Elena Mladova, CEO of MD Medical Group, said:

"We have now opened the thirtieth clinic in MD Medical Group's network as we continue to implement our regional development strategy. Kostroma is a new region for us, and once again we are the first mover into a region.

Previously, local residents had to travel to Moscow or other cities to receive medical treatment. Now, with the opening of "Mother and child Kostroma", our advanced IVF and gynaecological medical treatment will become more accessible for the more than 650 thousands residents of the region."

For further information please contact:

About MD Medical Group

MD Medical Group operates in the highly attractive Russian private healthcare service market and has a leading position in high-quality women's health and paediatrics. The company manages 29 modern healthcare facilities, including 4 hospitals and 25 outpatient clinics in Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Irkutsk, Novosibirsk, Irkutsk, Yaroslavl, Ryazan, Novokuznetsk, Krasnoyarsk, Omsk, and Barnaul.

The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG") in the form of Global Depositary Receipts (GDRs) since 12 October 2012.

Forward-Looking Statements:

This press release contains forward looking statements, which are based on the Company's current expectations and assumptions and may involve known and unknown risks and uncertainties that could cause actual results, performance or events to differ materially from those expressed or implied in such statements. The forward looking statements contained in this press release are based on past trends or activities and should not be taken that such trends or activities will continue in the future. It is believed that the expectations reflected in these statements are reasonable, but they may be affected by a number of variables which could cause actual results or trends to differ materially, including, but not limited to: conditions in the market, market position of the Company, earnings, financial position, cash flows, return on capital and operating margins, anticipated investments and economic conditions; the Company's ability to obtain capital/additional finance; a reduction in demand by customers; an increase in competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory developments, including, but not limited to, changes in environmental and health and safety regulations; exchange rate fluctuations; retention of senior management; the maintenance of labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as a result of financing arrangements.

No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.